Intraindividual variation in total and percent free prostate-specific antigen levels in prostate cancer suspects

Urologia Internationalis

Volumn 74, Issue 3, 2005, Pages 198-202

  Kobayashi, Minoru ^a   Kurokawa, Shinsuke ^a   Tokue, Akihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Intraindividual variation; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; BIOPSY; BLOOD; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 21244457170     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083548     Document Type: Article

References (21)

1. Oesterling JE: Prostatic-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
2. Morote J, Raventós CX, Lorente JA, Lopez MA, Encabo G, de Torres I, Andreu J: Comparison of percent free prostate-specific antigen and prostate-specific antigen density as methods to enhance prostate-specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate-specific antigen between 4.1 and 10 ng/ml. J Urol 1997;158:502-504.
3. Carter HB, Morrell CH, Person JD, Brant LJ, Plato CC, Metter EJ, Chan DW, Fozard JL, Walsh PC: Estimation of prostatic growth using serial prostate-specific antigen measurements of men with and without prostate disease. Cancer Res 1992;52:3323-3328.
4. Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW: Prospective use of free prostate-specific antigen to avoid repeated prostate biopsies in men with elevated total prostate-specific antigen. Urology 1996;48:76-80.
5. Reissigl A, Klocker H, Pointner J, Fink K, Horninger W, Ennemoser O, Strasser H, Colleselli K, Holtl L, Bartsch G: Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology 1996;48:2-22.
6. Recker F, Kwiatkowski MK, Piironen T, Petterson K. Goepel M, Scholl R: Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels. Br J Urol 1998;81:532-538.
7. Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC: Interpretation of free prostate-specific antigen clinical research studies for the detection of prostate cancer. J Urol 1998;159:5-12.
8. Shifman RB, Ahmann FR, Elvick A, Ahmann M, Coulis K, Brawer MK: Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 1987;33:2086-2088.
9. Dejtar SW, Martin JS, McPherson RA, Lynch JH: Dairy variability in human serum prostate-specific antigen and prostatic acid phosphatase: A comparative evaluation. Urology 1988;32:288-292.
10. Glenski WJ, Klee GG, Bergstralh EJ, Oestering JE: Prostate-specific antigen: Establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation and time on serum concentrations. Prostate 1992;21:99-110.
11. Pantegheni M, Pagani F, Bonora R: Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology. Eur J Chem Clin Biochem 1992;30:135-139.
12. Reihmann M, Rhodes PR, Cook TD, Grose GS, Bruskewitz RC: Analysis of variation in prostate-specific antigen values. Urology 1993;42:390-397.
13. Barry MJ, Gurman CJ, O'Leary MP, Walker-Corkey ES, Binkowitz BS, Cockett AT, Guess HA: Using repeated measures of symptoms score, uroflowmetry and prostate-specific antigen in he cyclical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group. J Urol 1995;153:99-103.
14. Komatsu K, Wehner N, Prestigiacomo AF, Chen Z, Stamy TA: Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology 1996;47:343-346.
15. Prestigiacomo AF, Stamey T: Physiological variation of serum prostate-specific antigen in the 4.0 to 10.0 ng/ml range in the male volunteers. J Urol 1996;155:1977-1980.
16. Roehrborn CG, Pickens GJ, Carmody T III: Variability of repeated serum prostate-specific antigen measurements within less than 90 days in a well-defined patient population. Urology 1996;47:59-66.
17. Ornstein DK, Smith DS, Rao GS, Basler JW, Ratliff TL, Catalona WJ: Biological variation of total, free and percent free serum prostate-specific antigen levels in screening volunteers. J Urol 1997;157:2179-2182.
18. Nixon RG, Wener MH, Smith KM, Parson RE, Strobel SA, Brawer MK: Biological variation of prostate-specific antigen levels in serum: An evaluation of day-to-day physiological fluctuations in a well- defined cohort of 24 patients. J Urol 1997;157:2183-2190.
19. Morote J, Raventós CX, Lorente JA, Enbabo G, López, de Torres I: Intraindividual variation of total and percent free serum prostate-specific antigen levels in patients with normal digital rectal examination. Eur Urol 1999;36:111-115.
20. Yan Y: Intraindividual variation of prostate specific antigen measurement and implications for early detection of prostate carcinoma. Cancer. 2001;92:776-780.
21. Bunting PS, DeBoer G, Choo R, Danjoux C, Klotz L, Fleshner N: Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem 2002;35:471-475.